Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Argenta Adds BioFocus to Genentech Pact | Contract Pharma
Breaking News, Collaborations & Alliances

Argenta Adds BioFocus to Genentech Pact

Argenta, a service division of Galapagos NV, has signed a contract extension with Genentech, allowing projects to be assigned to Galapagos’ service division, BioFocus.

Argenta, a service division of Galapagos NV, has signed a contract extension with Genentech, expanding their portfolio of projects in the collaboration and allowing Genentech to assign projects to Galapagos’ service division, BioFocus.

The Argenta/Genentech collaboration dates back to 2005 and covers several drug discovery programs that use Argenta’s computer-aided drug design (CADD), medicinal chemistry, and in vitro biology and screening to discover new chemical entities, against undisclosed Genentech drug targets. Under the extension, BioFocus will provide medicinal chemistry, in vitro biology and ADME services.

“We are delighted that Genentech has expanded its small-molecule drug discovery outsourcing into BioFocus, and we regard it as testament to the complementary expertise and technological capabilities that Argenta and BioFocus possess,” said Chris Newton, senior vice president, Galapagos Services.


Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters